Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,500
Closed -$47K 5966
2020
Q1
$47K Buy
+2,500
New +$46.1K ﹤0.01% 5264
2019
Q4
Sell
-1,200
Closed -$32K 6613
2019
Q3
$32K Buy
+1,200
New +$34.5K ﹤0.01% 6091
2019
Q2
Sell
-100
Closed -$3K 7103
2019
Q1
$3K Buy
+100
New +$3.05K ﹤0.01% 6804
2015
Q3
Sell
-100
Closed -$1K 6950
2015
Q2
$1K Buy
+100
New +$1.49K ﹤0.01% 6919
2014
Q4
Sell
-3,600
Closed -$54K 7458
2014
Q3
$54K Buy
3,600
+300
+9% +$6.08K ﹤0.01% 5818
2014
Q2
$79K Buy
3,300
+1,500
+83% +$35.1K ﹤0.01% 5599
2014
Q1
$40K Sell
1,800
-21,100
-92% -$459K ﹤0.01% 6173
2013
Q4
$481K Buy
22,900
+21,600
+1,662% +$450K ﹤0.01% 4130
2013
Q3
$39K Sell
1,300
-7,800
-86% -$250K ﹤0.01% 6192
2013
Q2
$239K Buy
+9,100
New +$244K ﹤0.01% 5002

Other funds holding LRN

Barclays's LRN Position: Q2 2026 in Review

Barclays increased its Stride (LRN) stake by 28% in Q2 2026, buying an estimated $3.12M and bringing the position to 154,229 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1341.

Barclays first reported a position in LRN in Q2 2013 and has held it in 47 quarters since. The position peaked at $44.7M in Q4 2025. 414 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

  • Barclays held 154,229 shares of Stride worth $13.3M as of Q2 2026.
  • Barclays bought 33,929 Stride shares in Q2 2026, an estimated $3.12M.
  • Stride made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1341 holding.
  • Barclays first reported a position in Stride in Q2 2013 and has held it in 47 quarters since.
  • Barclays's Stride position peaked at $44.7M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.